The estimated Net Worth of Capital Management, Llc Kol... is at least $74.5 Milion dollars as of 24 April 2009. Capital Kol owns over 15,759 units of Biospecifics Technologies stock worth over $74,507,114 and over the last 16 years Capital sold BSTC stock worth over $0.
Capital has made over 4 trades of the Biospecifics Technologies stock since 2009, according to the Form 4 filled with the SEC. Most recently Capital bought 15,759 units of BSTC stock worth $306,513 on 24 April 2009.
The largest trade Capital's ever made was buying 15,759 units of Biospecifics Technologies stock on 24 April 2009 worth over $306,513. On average, Capital trades about 6,828 units every 9 days since 2008. As of 24 April 2009 Capital still owns at least 841,603 units of Biospecifics Technologies stock.
You can see the complete history of Capital Kol stock trades at the bottom of the page.
Over the last 33 years, insiders at Biospecifics Technologies have traded over $67,860,045 worth of Biospecifics Technologies stock and bought 7,761,661 units worth $656,708,120 . The most active insiders traders include Capital Management, Llc Kol..., International Plc Endo oraz Max Link. On average, Biospecifics Technologies executives and independent directors trade stock every 73 days with the average trade being worth of $6,538,649. The most recent stock trade was executed by International Plc Endo on 2 December 2020, trading 7,344,955 units of BSTC stock currently worth $650,028,518.
Biospecifics Technologies executives and other stock owners filed with the SEC include: